Home › Blood Test Differentiates Men Who May Gain From Targeted Prostate Cancer Treatment

Blood Test Differentiates Men Who May Gain From Targeted Prostate Cancer Treatment

May 04, 2017

NEW YORK (GenomeWeb) – UK researchers have developed a blood test to differentiate men with prostate cancer who may benefit from targeted treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sep
20
Featured Webinar

Latest Advances in Tumor Genomic Profiling for Challenging Samples

This webinar will discuss how next-generation sequencing (NGS) can help clinical research labs and pathologists save time, money, and samples compared to single-analyte oncology research assays.

Sep
21
Featured Webinar

Processing Challenging Tumor Samples via Automated Tissue Dissection and Extraction-Free Library Prep

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.

Sep
27
Featured Webinar

Large-scale, Prospective Tumor and Normal Sequence to Accelerate Biomarker Discovery and Guide Clinical Care

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

What's Popular?

In Cancer

  1. Dutch Researchers Develop ThromboSeq Test to Detect Lung Cancer

  2. Biocept, UT Southwestern Partner for ALK Liquid Biopsy Study

  3. Diagenode to Commercialize Clinical Breast Cancer Test Based on New Epigenetic Signature

    Premium

  4. Oncocyte Q2 Net Loss Widens, First Test Still Slated for Q4 Launch

  5. Cynvenio, St. Luke's Partner on Breast Cancer Study

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.